
Harrow AAQS 2025
Harrow AAQS
4
Ticker
HROW
ISIN
US4158581094
WKN
A2PBJD
Harrow tiene un AAQS actual de 4.
Un alto AAQS puede ser considerado como un indicio positivo de que la empresa se está desarrollando exitosamente.
Los inversores pueden asumir que la empresa está en buen camino para obtener beneficios.
Por otro lado, es importante considerar el AAQS de la acción Harrow en comparación con las ganancias obtenidas y otras empresas de la misma industria. Un alto AAQS no garantiza absolutamente un futuro positivo. Solo de esta manera se puede obtener una imagen completa del rendimiento de la empresa.
Para poder valorar mejor el desarrollo de la empresa, es importante considerar el AAQS en comparación con otras empresas de la misma industria. En general, los inversores siempre deberían considerar el AAQS de una empresa en relación con otros indicadores como beneficio, EBIT, flujo de caja y otros para tomar una decisión de inversión informada.
Harrow Aktienanalyse
¿Qué hace Harrow?
Harrow Health Inc, with headquarters in San Diego, is a health company specialized in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 under the name Imprimis Pharmaceuticals and has since become a major player in the health market. The history of Harrow Health Inc. In 2012, Mark L. Baum and John J. Saharek founded Imprimis Pharmaceuticals to manufacture and distribute affordable medications. Mark L. Baum was already an experienced entrepreneur in the health technology sector and had previously founded Fusion Medical Technologies. John J. Saharek had extensive experience in the pharmaceutical industry before joining Imprimis. Imprimis began by manufacturing FDA-approved medications that were not available due to supply shortages or lack of alternatives. Later, the company expanded its offerings to include patent-free and cost-effective alternatives to expensive brand-name medications. During this time, Imprimis already gained experience with acquisitions. In 2017, the company acquired two companies, Sightrx and IV2You. The acquisition of Sightrx was an important step, as the company has an extensive portfolio of medications in the ophthalmology and wound treatment fields. In June 2019, the company changed its name to Harrow Health Inc. The renaming reflects the company's strategic realignment, aiming to expand its business and invest in new areas. The business model of Harrow Health Inc. Harrow Health is an integrated health company that encompasses various business areas. One of the main business areas of the company is the manufacturing of patent-free medications in various therapy fields, such as ophthalmology, dermatology, or pain management. Furthermore, Harrow Health Inc is also involved in the medical device sector. The company develops and distributes innovative products that contribute to the improvement of diagnosis and therapy. Another focus of the company is telemedicine. Harrow Health offers a platform that allows medical professionals to communicate with patients in real-time. The platform was developed to provide medical services in remote areas and emergency situations. Harrow Health aims to make medical services and products affordable and accessible. The company also enters innovative partnerships with healthcare providers to market its products and services. Divisions and products of Harrow Health Inc. Harrow Health is divided into different business areas, each specializing in different therapy fields. Harrow Health Ophthalmology specializes in the development and manufacturing of eye medications. The product range includes medications for dry eyes, eye infections, and glaucoma, among others. Harrow Health Dermatology distributes medications for the treatment of skin conditions, such as acne, psoriasis, or eczema. Harrow Health Neurology produces medications for pain management and treatment of neurological disorders. Harrow Health Pharmacy is a discount pharmacy network offering high-quality yet affordable medications. Harrow Health Medical Devices specializes in the development of medical devices. For example, the company has developed a device that allows painless injections without needles. Conclusion Harrow Health Inc is an innovative health company specialized in the development, manufacturing, and marketing of medical products and services. The company offers a wide range of products in various therapy fields and is also active in the medical device and telemedicine sectors. Harrow Health aims to make medical services and products affordable and accessible and cooperates with healthcare providers to achieve this goal. Harrow ist eines der beliebtesten Unternehmen auf Eulerpool.com.Preguntas frecuentes sobre la acción Harrow
Los planes de ahorro en acciones ofrecen una oportunidad atractiva para los inversores de construir riqueza a largo plazo. Una de las principales ventajas es el denominado efecto del coste promedio: al invertir regularmente una cantidad fija en acciones o fondos de acciones, se compran automáticamente más acciones cuando los precios son bajos y menos cuando son altos. Esto puede resultar en un precio promedio por acción más favorable a lo largo del tiempo. Además, los planes de ahorro en acciones permiten que los pequeños inversores accedan a acciones costosas, ya que pueden participar con pequeñas cantidades. La inversión regular también fomenta una estrategia de inversión disciplinada y ayuda a evitar decisiones emocionales, como la compra o venta impulsiva. Más aún, los inversores se benefician del potencial aumento en el valor de las acciones así como de los dividendos que se pueden reinvertir, lo que potencia el efecto del interés compuesto y, por ende, el crecimiento del capital invertido.
Andere Kennzahlen von Harrow
Nuestro análisis de acciones para la acción Harrow Ingresos incluye indicadores financieros importantes como ingresos, beneficios, P/E ratio, P/S ratio, EBIT, así como información sobre dividendos. Además, consideramos aspectos como acciones, capitalización de mercado, deudas, capital propio y obligaciones de Harrow Ingresos. Si busca información más detallada sobre estos temas, ofrecemos análisis en profundidad en nuestras subpáginas: